精彩推荐:青光眼 白内障 近视 远视 散光 斜视弱视 角膜溃疡 角膜炎 沙眼 眼外伤 更多疾病
大众频道
专业频道
时尚频道
互动频道
疾 病 | 保 健 | 爱眼动态 | 名医名院
知 识 | 美 食 | 自检自测 | 爱眼纪事
资 讯 | 临 床 | 学 术 | 文 献
图 谱 | 医 患 | 继 教 | 家 园
五官之美 | 整 形 | 美 容
眼镜一族 | 妆 容 | 图 库
眼科在线 | 预留位置
眼科知道 | 在线咨询
  当前位置:当前位置: 中华眼科在线 → 医学频道 → 学术论文汇编 → 2006第十一届 → 正文 切换到繁體中文 用户登录 新用户注册
Involvement of the RAGE Receptor ...

http://www.cnophol.com 2009-3-11 15:37:00 中华眼科在线

Involvement of the RAGE Receptor System and its ligands in the propagation of prolifervative vitreoretinopathy (PVR)

S.Hoffmann
Universitaetsaugenklinik Ulm, Ulm, Germany

Purpose: To investigate the involvement of the pro-inflammatory RAGE receptor system and its ligands in proliferative vitreoretinopathy (PVR).
Methods: Surgically removed PVR membranes were immunohistochemically stained for the expression of the RAGE receptor system and its ligands S100B, HMGB-1, S100A12, S100A7 and S100A8. Furthermore, functional aspects of S100B and HMGB-1 on the proliferation, migration and smooth muscle actin positivity of retinal pigmented epithelial cells (RPE) were evaluated.
Results: The RAGE receptor and its ligands S100B and S100A12 were strongly expressed in the excised PVR membranes. For HMGB-1 and S100A8, a weaker expression was seen, while S100A7 was not detected. RAGE was colocalized stromgly with RPE cells by double labeling for cytokeratin. Both HMGB-1 and S100B increased the proliferation and migration of RPE cells (p<0.05) in vitro. Furthermore, HMGB-1 induced a strong smooth muscle actin positivity of RPE cells after an exposure time of 5 days.
Conclusions: The RAGE multiligand system with its ligands S100A12, S100B, S100A8 and HMGB-1 may be involved in the propagation of PVR and should be further evaluated for feasibility as a therapeutic target.

声明:本站独家报道,转载须标明来源“中华眼科在线”

(来源:中华眼科在线)(责编:duzhanhui)

发表评论】【加入收藏】【告诉好友】【打印此文】【关闭窗口
  • 下一条信息:
  • 更多关于(眼睛,中华眼科在线,2006年,第十一界眼科学术大会会议指南及论文摘要)的信息
      热门图文

    秘黑线条如何打造

    美目妙计 绽放“睛”彩

    让眼睛即刻清亮的秘密

    时髦烟熏妆的新画法
      健康新看点
      健康多视点
      图话健康

    Copyright © 2007 中华眼科在线 网站备案序列号: 京ICP备08009675号
    本网站由五景药业主办 北京金鼎盛世医学传媒机构负责运营 国家医学教育发展中心提供学术支持
    服务电话:010-63330565 服务邮箱: [email protected]